US FDA accepts Evoke's CMC and PK trial plan for nasal metoclopramide
The US FDA has accepted a manufacturing and trial plan for Evoke Pharma's Gimoti, the nasal metoclopramide formulation that fell short in a Phase III trial last year.
Archives for April 4, 2017
US FDA hits Indoco with warning due to leaky glaucoma drug
Leakage problems for of an ophthalmic drug has landed contract manufacturer Indoco Remedies with a US FDA warning letter at its plant in Goa.